Therapeutic Drug Monitoring for Patients with HIV Infection
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 26 (2) , 107-109
- https://doi.org/10.1097/00007691-200404000-00003
Abstract
This paper provides a brief overview of therapeutic drug monitoring (TDM) in patients with HIV infection. The manuscipt not only focuses on an update on TDM in HIV infection but also provides the latest information on tandem mass spectrometric methods for antiretroviral drug quantification. Also discussed are the preliminary new and original data on free antiretroviral drug measurement in both plasma and saliva.Keywords
This publication has 9 references indexed in Scilit:
- Improved Method for Concurrent Quantification of Antiretrovirals by Liquid Chromatography-Tandem Mass SpectrometryTherapeutic Drug Monitoring, 2003
- Reverse Phase High-Performance Liquid Chromatography Method for the Analysis of Amprenavir, Efavirenz, Indinavir, Lopinavir, Nelfinavir and Its Active Metabolite (M8), Ritonavir, and Saquinavir in Heparinized Human PlasmaTherapeutic Drug Monitoring, 2003
- Critical Issues in Therapeutic Drug Monitoring of Antiretroviral DrugsTherapeutic Drug Monitoring, 2002
- Simple rapid method for quantification of antiretrovirals by liquid chromatography—tandem mass-spectrometryClinical Biochemistry, 2002
- Pharmacokinetic and Other Drug Interactions in Patients With AIDSTherapeutic Drug Monitoring, 2001
- Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt StudyAIDS, 2000
- Using Pharmacokinetics to Optimize Antiretroviral Drug-Drug Interactions in the Treatment of Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2000
- The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individualsAIDS, 2000
- Therapeutic Drug Monitoring of Antiretrovirals in Human Immunodeficiency Virus InfectionTherapeutic Drug Monitoring, 2000